ResMed

  • Press Releases

    ResMed’s Astral Life Support Ventilator Now Has AutoEPAP in U.S.

    SAN DIEGO–(BUSINESS WIRE)–ResMed (NYSE: RMD) (ASX: RMD), a global leader in cloud-connected respiratory care devices, today announced key upgrades to its Astral life support ventilators, including Optional AutoEPAP in iVAPS for U.S. patients, a high-demand therapy option. AutoEPAP now available for U.S. Astral ventilator users, plus worldwide upgrades for ease of use and peace of mind. #respiratorycare Tweet this What…

    Read More »
  • Press Releases

    ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers

    SAN DIEGO & SOUTH SAN FRANCISCO–(BUSINESS WIRE)–ResMed (NYSE: RMD, ASX: RMD), a global leader in sleep apnea treatment and connected health solutions, and Verily, an Alphabet company, today announced their agreement to form a new joint venture. .@ResMed and Verily to form joint venture to help reach millions of untreated #SleepApnea sufferers Tweet this Combining ResMed’s expertise in sleep apnea…

    Read More »
Back to top button